Arash Nabbi

I am a computational biologist and a pharmacist focusing on biomarker research for immuno-oncology. My training spans across computational and experimental approaches in several adult and childhood cancers. My work involves applying advanced technologies to determine mechanisms of immunotherapy and identify predictive biomarkers for immunotherapy.

I pursued my post-doctoral training in Dr. Trevor Pugh’s laboratory at the Princess Margaret Cancer Center located in Toronto, ON. I had the opportunity to work on several translational research projects focused on the immunogenomics of pediatric cancers.

I hold a PhD in cancer biology from the Cumming school of medicine at the University of Calgary. During my studies, I focused on investigating epigenetic and post-translational regulation of Androgen Receptor pathway and its impact on the progression of prostate cancer.

Research interests:

• Predictive immune biomarkers to guide prospective clinical trials
• Identification of novel targets of cancer immunotherapy using a combination of computational and experimental approaches
• Tumour-Immune evolution over the course of disease/treatment